Non-ownership Filings
| FDA Grants Orphan Drug Designation | Mar. 03, 2025 |
| Annual Report 2024 published | Feb. 27, 2025 |
| Financial Statement 1 January to 31 December 2024 | Feb. 27, 2025 |
| Notice of Financial Statement and Annual Report | Feb. 19, 2025 |
| Change of Broker | Feb. 11, 2025 |
| Results of Oversubscribed Placing | Feb. 06, 2025 |
| Proposed Issue and Placing | Feb. 05, 2025 |
Ownership Update Filings
| Holding(s) in Company | Feb. 14, 2025 |
| Holding(s) in Company | Feb. 06, 2025 |
| Grant of options | Aug. 30, 2024 |
| Grant of options | Aug. 07, 2024 |
| Holding(s) in Company - Replacement | Jun. 25, 2024 |
| Announcement of Placing | Apr. 04, 2024 |
| Grant of options | Dec. 04, 2023 |